Table 3. Bone turnover outcomes.

Outcome – Univariable Analysis *	N	HIV Status	Median (95% CI)	Difference	P
CTx (ng/mL)	57	HIV-	0.19 (0.15, 0.28)	0.12 (0.02, 0.22)	0.007
	61	HIV+	0.31 (0.22, 0.38)
Osteocalcin (ng/mL)	58	HIV-	6.0 (5.4, 7.2)	−1.2 (−2.5, 0.1)	0.06
	61	HIV+	4.9 (3.4, 5.3)
Outcome – Multivariable Analysis †	N	HIV Status	Adjusted Geometric Mean (95% CI)	Geometric Mean Ratio (95% CI)	P
CTx (ng/mL)	56	HIV-	0.20 (0.15, 0.26)	1.51 (1.09, 2.10)	0.01
	61	HIV+	0.30 (0.23, 0.40)
Osteocalcin (ng/mL)	57	HIV-	6.53 (5.14, 8.30)	0.72 (0.53, 0.97)	0.03
	61	HIV+	4.71 (3.66, 6.08)

*Characteristics are compared between HIV serostatus groups with Wilcoxon rank-sum test for CTx and osteocalcin.

^†Multivariable analysis adjusted for age, gender, race, BMI, smoking, past 30 day alcohol consumption and fracture history